8821/13381US=23 / Câncer
Esposito NN, Dabbs DJ. Phyllodes tumours of the breast: prognostic assessment using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 263-73. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; AVALIACAO PROGNOSTICA; MARCADORES DE PROLIFERACAO CELULAR; GENES SUPRESSORES DE TUMOR; P53; RECEPTORES DE ESTEROIDES; PROTEINAS; FATORES DE CRESCIMENTO EPIDERMICO; HER-2/NEU; ANALISE CROMOSSOMICA; ANALISE MOLECULAR; ANALISE HISTOPATOLOGICA

8822/13381US=23 / Câncer
Tot T. Metaplastic breast carcinoma: detection using histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 275-90. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA DE MAMA METAPLASICO; HISTOLOGIA; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS; PROGNOSTICO

8823/13381US=23 / Câncer
van Diest PJ, Moelans CB, Purnomosari D, Pals G, de Weger RA. Invasive breast cancer: overexpression of HER-2 determined by immunohistochemistry and multiplex ligation-dependent probe amplification. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 291-304. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA INVASIVO; SUPEREXPRESSAO DE HER-2; IMUNOHISTOQUIMICA; LIGADURA MULTIPLEX DEPENDENTE

8824/13381US=23 / Câncer
Kaufmann M, Loibl S, von Minckwitz G. Operable breast cancer: neoadjuvant treatment (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 305-18. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA OPERAVEL; TRATAMENTO NEOADJUVANTE; CANCER DE MAMA. DIAGNOSTICO; CANCER DE MAMA. TRATAMENTO

8825/13381US=23 / Câncer
McCubrey JA, Franklin RA, Navolanic PM, Martelli AM, Steelman LS. Chemotherapy for breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 319-25. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; QUIMIOTERAPIA; METOTREXATO; 5-FLUOROURACIL; CICLOFOSFAMIDA; ANTRACICLINA; TAXANOS; TRASTUZUMABE; TAMOXIFENO; INIBIDORES DE AROMATASE

8826/13381US=23 / Câncer
Frasci G, D'Aiuto G, Iodice G, D'Aiuto M, Comella G. Locally advanced breast cancer: role of chemotherapy in improving prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 327-49. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA LOCALMENTE AVANCADO; QUIMIOTERAPIA; QUIMIOTERAPIA PRE-OPERATORIA; QUIMIOTERAPIA POS-OPERATORIA; TRATAMENTO NEOADJUVANTE; TERAPIA-ALVO

8827/13381US=23 / Câncer
Kummel S, Rezai M, Kimmig R, Schmid P. Relevance of dose-intensity for adjuvant treatment of breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 351-60. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TRATAMENTO ADJUVANTE; DOSE DE INTENSIDADE

8828/13381US=23 / Câncer
Pallis AG, Georgoulias V, Mavroudis V. Advanced breast cancer: treatment with docetaxel/epirubicin. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 361-71. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA AVANCADO; CANCER DE MAMA. TRATAMENTO; DOCETAXEL; EPIRRUBICINA; COMBINACAO ANTRACICLINA-TAXANO; COMBINACAO DOCETAXEL EPIRRUBICINA; DADOS FARMACOCINETICOS

8829/13381US=23 / Câncer
Erban JK, Lau J. Systemic therapy for breast cancer: using toxicity data to inform decisions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 373-94. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TERAPIA SISTEMICA; DADOS DE TOXICIDADE; TERAPIA HORMONAL; QUIMIOTERAPIA; TERAPIAS-ALVO; TOXICIDADE AGUDA; SEQUELAS

8830/13381US=2 / Tórax
Prokhorov AV, Ford KF, Hudmon KS. Smoking cessation. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 1-19. ISBN 978-1-4051-5112-2.

CESSACAO DO TABAGISMO; FUMO. CANCER DE PULMAO; FUMO PASSIVO. CANCER DE PULMAO; TABAGISMO. PACIENTES COM CANCER DE PULMAO

8831/13381US=23 / Câncer
Morabito A, Piccirillo MC, Bryce J, Monaco K, De Feo G, Del Giudice A, Falasconi F, Perrone F. Chemotherapy for metastatic breast cancer patients who received adjuvant anthracyclines (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 395-414. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA METASTATICO; QUIMIOTERAPIA; ANTRACICLINAS ADJUVANTES; HER-2

8832/13381US=2 / Tórax
Bailey-Wilson JE. Lung cancer susceptibility genes. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 20-32. ISBN 978-1-4051-5112-2.

PULMAO GENES DE SUSCEPTIBILIDADE AO CANCER; INALACAO DE FUMACA DE TABACO; ANALISE DE LIGACAO DE CANCER DE PULMAO

8833/13381US=23 / Câncer
Frasci G, D'Aiuto G, Iodice G, Thomas R, D'Aiuto M, Comella G. Estrogen receptor-negative and HER-2/neu-positive locally advanced breast carcinoma: therapy with paclitaxel and granulocyte-colony stimulating factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 415-32. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA DE MAMA; ESTROGENIO; RECEPTOR-NEGATIVO; HER-2/NEU-POSITIVE; PACLITAXEL; COLONIAS DE GRANULOCITOS; RECEPTORES HORMONAIS; RESPOSTA A QUIMIOTERAPIA

8834/13381US=23 / Câncer
Benson JR, Turner EH, Winters Z. Breast cancer: side effects of tamoxifen and anastrozole. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 433-57. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TAMOXIFENO; ANASTROZOL; TERAPIA ANTI-HORMONAL; CANCER DE MAMA AVANCADO; TERAPIA HORMONAL NEOADJUVANTE; TERAPIA HORMONAL ADJUVANTE; QUIMIOPREVENCAO; INIBIDORES DE AROMATASE

8835/13381US=23 / Câncer
Shackney SE, Emlet DR, Schwartz R, Brown KA, Pollice AA, Smith CA. Breast cancer: expression of HER-2 and epidermal growth factor receptor as clinical markers for response to targeted therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 459-82. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; EXPRESSAO DO RECEPTOR HER-2; FATOR DE CRESCIMENTO EPIDERMICO; RESPOSTA A TERAPIA-ALVO; IMUNOHISTOQUIMICA; HIBRIDACAO IN SITU FLUORESCENTE

8836/13381US=23 / Câncer
Bafford AC, Garber JE, Chittenden A, Golshan M. Young breast cancer patients undergoing breast-conserving therapy: role of BRCA1 and BRCA2. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 483-91. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; PACIENTES JOVENS; TERAPIA CONSERVADORA DA MAMA; BRCA1; BRCA2

8837/13381US=23 / Câncer
Smith BD. Radiation therapy for older women with early breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 493-506. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; RADIOTERAPIA; CANCER DE MAMA PRECOCE

8838/13381US=23 / Câncer
Tan XL, Popanda O, Chang-Claude J. Acute side effects of radiotherapy in breast cancer patients: role of DNA-repair and cell cycle control genes. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 507-28. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; RADIOTERAPIA; EFEITOS COLATERAIS; REPARO DO DNA; CELULAS GENES; CONTROLE DE CICLO

8839/13381US=35 / Biol/Mol
Weinberg RA. Cancer: a genetic disorder. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 3-16. ISBN 978-1-4160-3703-3.

CANCER; GENETICA; ONCOGENE CELULAR; TUMORIGENESE; GENES SUPRESSORES DE TUMOR; GENOMA; MECANISMOS EPIGENETICOS; PROLIFERACAO IMORTALIZADO

8840/13381US=35 / Biol/Mol
Bafico A, Grumolato L, Aaronson SA. Oncogenes and signal transduction. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 17-30. ISBN 978-1-4160-3703-3.

ONCOGENE; TRANSDUCAO DE SINAL; RECEPTORES DE TIROSINA-QUINASE; RECEPTORES DE CITOCINA; NEUROTRANSMISSORES; SINALIZACAO WNT; TERAPIA DO CANCER

Primeira | Anterior | Próxima | Última